SEC 13F Intelligence

Global Imc LLC / XENE

Global Imc LLC’s Xenon Pharmaceuticals Inc Position

Does Global Imc LLC own Xenon Pharmaceuticals Inc (XENE)? Not currently — the last reported position was 146.4K shares worth $6M in Q4 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$6M
Q4 2022
Shares
146.4K
% of Portfolio
+1.49%
Quarters Held
3
position exited

Position History XENE

Reported value by quarter
Q2 ’22: $5MQ2 ’22Q3 ’22: $6MQ3 ’22Q4 ’22: $6MQ4 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2022146.4K$6M+1.49%
Q3 2022154.5K$6M+1.48%
Q2 2022150.5K$5M+1.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Global Imc LLC’s full portfolio or all institutional holders of XENE.